Literature DB >> 30132190

Lung cancer patients with a previous extra-pulmonary malignancy should not be considered homogeneous: a clinicopathological analysis of 3530 surgical cases.

X-L Hu1, S-T Xu2, X-C Wang1, D-N Hou1, C Bao1, D Yang3, Y-L Song1.   

Abstract

BACKGROUND: Lung cancer patients with a previous extra-pulmonary malignancy have been widely discussed for their postoperative prognosis. Still, whether different types of previous extra-pulmonary malignancy confer different clinicopathological features and outcomes of lung cancer patients deserves further investigation.
METHODS: The medical records of patients undergoing operation for pulmonary malignancy were retrospectively reviewed. After identifying primary lung cancer out of pulmonary metastasis in patients with a history of previous extra-pulmonary malignancy, clinicopathological parameters and postoperative prognosis were compared between lung cancer patients without and with different types of previous extra-pulmonary malignancy.
RESULTS: Approximately, 5.0% lung cancer patients undergoing surgery had a previous extra-pulmonary malignancy. Prior breast cancer (20%) and colorectal cancer (16%) formed the majority of these previous extra-pulmonary malignancies. Many clinicopathological features such as reason for visit, tumor size and histological subtype were significantly different between lung cancer patients without and with different types of previous extra-pulmonary malignancy (P < 0.05). Lung cancer patients with a previous occurrence of breast cancer were the most different type from patients without a previous extra-pulmonary malignancy in clinicopathological features (P < 0.05). The postoperative overall survival was not significantly different between lung cancer patients without and with different types of previous extra-pulmonary malignancy (P > 0.05).
CONCLUSION: Previous extra-pulmonary malignancy was confirmed to be harmless to postoperative prognosis of lung cancer patients. Lung cancer patients with a previous extra-pulmonary malignancy, especially with a previous occurrence of breast cancer, were highly heterogeneous in clinicopathological features. These findings implied there might be a unique etiology existing in lung cancer following a previous occurrence of breast cancer.

Entities:  

Keywords:  Clinicopathological feature; Extra-pulmonary malignancy; Lung cancer; Surgery

Mesh:

Year:  2018        PMID: 30132190     DOI: 10.1007/s12094-018-1933-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  20 in total

1.  Prognosis of lung cancer patients with a past history of colorectal cancer.

Authors:  Aritoshi Hattori; Kenji Suzuki; Keiju Aokage; Takahiro Mimae; Kanji Nagai; Masahiro Tsuboi; Morihito Okada
Journal:  Jpn J Clin Oncol       Date:  2014-08-24       Impact factor: 3.019

2.  Characteristics of lung cancer after a previous malignancy.

Authors:  Niels Reinmuth; Patrick Stumpf; Andreas Stumpf; Thomas Muley; Sonja Kobinger; Hans Hoffmann; Felix J F Herth; Philipp A Schnabel; Helge Bischoff; Michael Thomas
Journal:  Respir Med       Date:  2014-03-05       Impact factor: 3.415

3.  Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?

Authors:  Geena X Wu; Rebecca A Nelson; Jae Y Kim; Dan J Raz
Journal:  Clin Lung Cancer       Date:  2017-03-02       Impact factor: 4.785

4.  History of multiple previous malignancies should not be a contraindication to the surgical resection of lung cancer.

Authors:  Pierre-Benoit Pagès; Pierre Mordant; Bertrand Grand; Alain Badia; Christophe Foucault; Antoine Dujon; Françoise Le Pimpec-Barthes; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2013-01-31       Impact factor: 4.330

5.  Prognosis of lung cancer resection in patients with previous extra-respiratory solid malignancies.

Authors:  Pierre Benoit Pagès; Pierre Mordant; Aurélie Cazes; Bertrand Grand; Christophe Foucault; Antoine Dujon; Françoise Le Pimpec Barthes; Marc Riquet
Journal:  Eur J Cardiothorac Surg       Date:  2013-02-07       Impact factor: 4.191

6.  Primary lung cancer and extrapulmonary malignancy.

Authors:  Hans-Stefan Hofmann; Heinz Neef; Peter Schmidt
Journal:  Eur J Cardiothorac Surg       Date:  2007-08-17       Impact factor: 4.191

7.  Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule.

Authors:  Carlos M Mery; Anastasia N Pappas; Raphael Bueno; Steven J Mentzer; Jeanne M Lukanich; David J Sugarbaker; Michael T Jaklitsch
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

8.  Epidemiology of lung cancer in China.

Authors:  Wanqing Chen; Rongshou Zheng; Hongmei Zeng; Siwei Zhang
Journal:  Thorac Cancer       Date:  2015-03-02       Impact factor: 3.500

9.  Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.

Authors:  Shan Shan; Jun She; Zhi-Qiang Xue; Chun-Xia Su; Shen-Xiang Ren; Feng-Ying Wu
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

10.  Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.

Authors:  Sandi L Pruitt; Andrew L Laccetti; Lei Xuan; Ethan A Halm; David E Gerber
Journal:  Br J Cancer       Date:  2017-02-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.